APPLICATION
ANDA090215
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-12
LATEST ACTION
2010-05-12
ROUTE
TOPICAL
DOSAGE FORM
SWAB
MARKETING STATUS
Prescription
Products
ERYTHROMYCINPrescription
ERYTHROMYCIN 2% · SWAB · TOPICAL
Approval history
2010-05-12OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.